Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Unipolar depression in adults: Course of illness

William Coryell, MD
Section Editor
Peter P Roy-Byrne, MD
Deputy Editor
David Solomon, MD


Major depressive disorder (unipolar major depression) and persistent depressive disorder (dysthymia) represent depressive syndromes that are distinguished by the type and number of symptoms that occur as well as their duration. Depressive symptoms can include depressed mood, loss of interest or pleasure in most or all activities, insomnia or hypersomnia, change in appetite or weight, psychomotor retardation or agitation, low energy, poor concentration, thoughts of worthlessness or guilt, and recurrent thoughts about death or suicide [1]. The World Health Organization estimated that major depressive disorder was the 11th greatest cause of disability and mortality in the world among 291 diseases and causes of injuries [2].

Preliminary studies suggest that course of illness may be associated with structural brain changes. As an example, a one-year prospective magnetic imaging study followed patients with treatment resistant unipolar major depression (n = 26) who were treated with pharmacotherapy, and found that remission was associated with subtle increases in hippocampal volume and cortical thickness, whereas nonremission was associated with decreased volume and thickness [3].

This topic reviews the course of illness in patients with major depressive disorder and persistent depressive disorder (dysthymia). The course of illness in psychotic depression and minor depression is discussed separately, as is the epidemiology, clinical features, diagnosis, and treatment of depression:

(See "Unipolar major depression with psychotic features: Maintenance treatment and course of illness", section on 'Course of illness'.)

(See "Unipolar minor depression in adults: Epidemiology, clinical presentation, and diagnosis", section on 'Course of illness'.)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 21, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.
  2. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197.
  3. Phillips JL, Batten LA, Tremblay P, et al. A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression. Int J Neuropsychopharmacol 2015; 18.
  4. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 2006; 31:1841.
  5. Eaton WW, Shao H, Nestadt G, et al. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008; 65:513.
  6. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55:694.
  7. Keitner GI, Posternak MA, Ryan CE. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry 2003; 64:1091.
  8. Zimmerman M, Chelminski I, Posternak MA. Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry 2005; 162:1370.
  9. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002; 159:469.
  10. Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 2007; 61:631.
  11. Chen L, Eaton WW, Gallo JJ, Nestadt G. Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. J Affect Disord 2000; 59:1.
  12. Jabben N, Penninx BW, Beekman AT, et al. Co-occurring manic symptomatology as a dimension which may help explaining heterogeneity of depression. J Affect Disord 2011; 131:224.
  13. Coryell W, Akiskal HS, Leon AC, et al. The time course of nonchronic major depressive disorder. Uniformity across episodes and samples. National Institute of Mental Health Collaborative Program on the Psychobiology of Depression--Clinical Studies. Arch Gen Psychiatry 1994; 51:405.
  14. Solomon DA, Keller MB, Leon AC, et al. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997; 54:1001.
  15. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289:3095.
  16. Fiedorowicz JG, Endicott J, Leon AC, et al. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry 2011; 168:40.
  17. Chen MH, Chen YS, Hsu JW, et al. Comorbidity of ADHD and subsequent bipolar disorder among adolescents and young adults with major depression: a nationwide longitudinal study. Bipolar Disord 2015; 17:315.
  18. Bukh JD, Andersen PK, Kessing LV. Rates and predictors of remission, recurrence and conversion to bipolar disorder after the first lifetime episode of depression--a prospective 5-year follow-up study. Psychol Med 2016; 46:1151.
  19. Clayton PJ, Guze SB, Cloninger CR, Martin RL. Unipolar depression: diagnostic inconsistency and its implications. J Affect Disord 1992; 26:111.
  20. Kessing LV. Diagnostic stability in depressive disorder as according to ICD-10 in clinical practice. Psychopathology 2005; 38:32.
  21. Schwartz JE, Fennig S, Tanenberg-Karant M, et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000; 57:593.
  22. Tsuang MT, Woolson RF, Winokur G, Crowe RR. Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. Arch Gen Psychiatry 1981; 38:535.
  23. Salvatore P, Baldessarini RJ, Tohen M, et al. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry 2011; 72:183.
  24. Bromet EJ, Kotov R, Fochtmann LJ, et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry 2011; 168:1186.
  25. Khan A, Dager SR, Cohen S, et al. Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology 1991; 4:125.
  26. Quitkin FM, Rabkin JG, Ross D, Stewart JW. Identification of true drug response to antidepressants. Use of pattern analysis. Arch Gen Psychiatry 1984; 41:782.
  27. Holma KM, Holma IA, Melartin TK, et al. Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry 2008; 69:196.
  28. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr (1985) 1995; 146:5.
  29. Keller MB, Klerman GL, Lavori PW, et al. Long-term outcome of episodes of major depression. Clinical and public health significance. JAMA 1984; 252:788.
  30. Szádóczky E, Rózsa S, Zámbori J, Füredi J. Predictors for 2-year outcome of major depressive episode. J Affect Disord 2004; 83:49.
  31. Swindle RW Jr, Cronkite RC, Moos RH. Risk factors for sustained nonremission of depressive symptoms: a 4-year follow-up. J Nerv Ment Dis 1998; 186:462.
  32. Lamers F, Beekman AT, van Hemert AM, et al. Six-year longitudinal course and outcomes of subtypes of depression. Br J Psychiatry 2016; 208:62.
  33. Angst J. The course of affective disorders. Psychopathology 1986; 19 Suppl 2:47.
  34. Coryell W, Leon A, Winokur G, et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996; 153:483.
  35. Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord 2004; 81:123.
  36. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry 1991; 148:1512.
  37. Coryell W, Endicott J, Winokur G. Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. Am J Psychiatry 1992; 149:100.
  38. Coryell W, Fiedorowicz JG, Solomon D, et al. Effects of anxiety on the long-term course of depressive disorders. Br J Psychiatry 2012; 200:210.
  39. Kelly KM, Mezuk B. Predictors of remission from generalized anxiety disorder and major depressive disorder. J Affect Disord 2017; 208:467.
  40. Grilo CM, Stout RL, Markowitz JC, et al. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. J Clin Psychiatry 2010; 71:1629.
  41. Skodol AE, Grilo CM, Keyes KM, et al. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry 2011; 168:257.
  42. Bukh JD, Andersen PK, Kessing LV. Personality and the Long-Term Outcome of First-Episode Depression: A Prospective 5-Year Follow-Up Study. J Clin Psychiatry 2016; 77:e704.
  43. Scott J, Eccleston D, Boys R. Can we predict the persistence of depression? Br J Psychiatry 1992; 161:633.
  44. Hirschfeld RM, Klerman GL, Andreasen NC, et al. Psycho-social predictors of chronicity in depressed patients. Br J Psychiatry 1986; 148:648.
  45. Steunenberg B, Beekman AT, Deeg DJ, Kerkhof AJ. Personality predicts recurrence of late-life depression. J Affect Disord 2010; 123:164.
  46. Sherrington JM, Hawton K, Fagg J, et al. Outcome of women admitted to hospital for depressive illness: factors in the prognosis of severe depression. Psychol Med 2001; 31:115.
  47. Solomon DA, Leon AC, Coryell W, et al. Predicting recovery from episodes of major depression. J Affect Disord 2008; 107:285.
  48. Spijker J, de Graaf R, Bijl RV, et al. Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2004; 81:231.
  49. Gilman SE, Trinh NH, Smoller JW, et al. Psychosocial stressors and the prognosis of major depression: a test of Axis IV. Psychol Med 2013; 43:303.
  50. Stegenga BT, Geerlings MI, Torres-González F, et al. Risk factors for onset of multiple or long major depressive episodes versus single and short episodes. Soc Psychiatry Psychiatr Epidemiol 2013; 48:1067.
  51. Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry 2012; 169:141.
  52. Garcia-Toro M, Rubio JM, Gili M, et al. Persistence of chronic major depression: a national prospective study. J Affect Disord 2013; 151:306.
  53. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition, 2010. http://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on May 29, 2011).
  54. Depression: The Treatment and Management of Depression in Adults, National Clinical Practice Guideline 90, 2010 http://guidance.nice.org.uk/CG90 (Accessed on May 29, 2011).
  55. Bulloch A, Williams J, Lavorato D, Patten S. Recurrence of major depressive episodes is strongly dependent on the number of previous episodes. Depress Anxiety 2014; 31:72.
  56. Hardeveld F, Spijker J, De Graaf R, et al. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2013; 43:39.
  57. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157:229.
  58. Keller MB, Lavori PW, Lewis CE, Klerman GL. Predictors of relapse in major depressive disorder. JAMA 1983; 250:3299.
  59. Pintor L, Torres X, Navarro V, et al. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord 2004; 82:291.
  60. Giles DE, Jarrett RB, Biggs MM, et al. Clinical predictors of recurrence in depression. Am J Psychiatry 1989; 146:764.
  61. Kessing LV. Severity of depressive episodes according to ICD-10: prediction of risk of relapse and suicide. Br J Psychiatry 2004; 184:153.
  62. Maj M, Veltro F, Pirozzi R, et al. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992; 149:795.
  63. Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999; 156:1000.
  64. ten Doesschate MC, Bockting CL, Koeter MW, et al. Prediction of recurrence in recurrent depression: a 5.5-year prospective study. J Clin Psychiatry 2010; 71:984.
  65. Karsten J, Hartman CA, Smit JH, et al. Psychiatric history and subthreshold symptoms as predictors of the occurrence of depressive or anxiety disorder within 2 years. Br J Psychiatry 2011; 198:206.
  66. Colman I, Naicker K, Zeng Y, et al. Predictors of long-term prognosis of depression. CMAJ 2011; 183:1969.
  67. van Loo HM, Aggen SH, Gardner CO, Kendler KS. Multiple risk factors predict recurrence of major depressive disorder in women. J Affect Disord 2015; 180:52.
  68. Nierenberg AA, Husain MM, Trivedi MH, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med 2010; 40:41.
  69. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000; 157:1501.
  70. Kiosses DN, Alexopoulos GS. The prognostic significance of subsyndromal symptoms emerging after remission of late-life depression. Psychol Med 2013; 43:341.
  71. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998; 50:97.
  72. Judd LL, Schettler PJ, Rush AJ, et al. A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness. J Clin Psychiatry 2016; 77:1065.
  73. Coryell W, Endicott J, Keller MB. Predictors of relapse into major depressive disorder in a nonclinical population. Am J Psychiatry 1991; 148:1353.
  74. Eaton WW, Anthony JC, Gallo J, et al. Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 1997; 54:993.
  75. Zisook S, Lesser I, Stewart JW, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry 2007; 164:1539.
  76. Abravanel BT, Sinha R. Emotion dysregulation mediates the relationship between lifetime cumulative adversity and depressive symptomatology. J Psychiatr Res 2015; 61:89.
  77. Fekadu A, Wooderson SC, Markopoulo K, et al. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 2009; 116:4.
  78. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905.
  79. Olin B, Jayewardene AK, Bunker M, Moreno F. Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention. PLoS One 2012; 7:e48002.
  80. de Jonge P, Conradi HJ, Kaptein KI, et al. Duration of subsequent episodes and periods of recovery in recurrent major depression. J Affect Disord 2010; 125:141.
  81. Kennedy N, Abbott R, Paykel ES. Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. Br J Psychiatry 2004; 184:330.
  82. Angst J, Gamma A, Sellaro R, et al. Recurrence of bipolar disorders and major depression. A life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003; 253:236.
  83. Coryell W, Solomon D, Leon A, et al. Does major depressive disorder change with age? Psychol Med 2009; 39:1689.
  84. van Loo HM, Cai T, Gruber MJ, et al. Major depressive disorder subtypes to predict long-term course. Depress Anxiety 2014; 31:765.
  85. Coryell W, Endicott J, Winokur G, et al. Characteristics and significance of untreated major depressive disorder. Am J Psychiatry 1995; 152:1124.
  86. Leon AC, Solomon DA, Mueller TI, et al. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med 1999; 29:869.
  87. Trivedi MH, Morris DW, Wisniewski SR, et al. Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry 2013; 170:633.
  88. van der Voort TY, Seldenrijk A, van Meijel B, et al. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder. J Clin Psychiatry 2015; 76:e809.
  89. IsHak WW, Mirocha J, James D, et al. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up. Acta Psychiatr Scand 2015; 131:51.
  90. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington DC 2000.
  91. McCullough JP Jr, Klein DN, Keller MB, et al. Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction. J Abnorm Psychol 2000; 109:419.
  92. McCullough JP Jr, Klein DN, Borian FE, et al. Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2. J Abnorm Psychol 2003; 112:614.
  93. Klein DN, Shankman SA, Lewinsohn PM, et al. Family study of chronic depression in a community sample of young adults. Am J Psychiatry 2004; 161:646.
  94. Yang T, Dunner DL. Differential subtyping of depression. Depress Anxiety 2001; 13:11.
  95. Gonzales LR, Lewinsohn PM, Clarke GN. Longitudinal follow-up of unipolar depressives: an investigation of predictors of relapse. J Consult Clin Psychol 1985; 53:461.
  96. Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry 2006; 163:872.
  97. Klein DN, Taylor EB, Dickstein S, Harding K. Primary early-onset dysthymia: comparison with primary nonbipolar nonchronic major depression on demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. J Abnorm Psychol 1988; 97:387.
  98. Keller MB, Lavori PW, Endicott J, et al. "Double depression": two-year follow-up. Am J Psychiatry 1983; 140:689.
  99. Keller MB, Klein DN, Hirschfeld RM, et al. Results of the DSM-IV mood disorders field trial. Am J Psychiatry 1995; 152:843.
  100. Klein DN, Schwartz JE, Rose S, Leader JB. Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study. Am J Psychiatry 2000; 157:931.
  101. Hayden EP, Klein DN. Outcome of dysthymic disorder at 5-year follow-up: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress. Am J Psychiatry 2001; 158:1864.
  102. Klein DN, Shankman SA, Rose S. Dysthymic disorder and double depression: prediction of 10-year course trajectories and outcomes. J Psychiatr Res 2008; 42:408.
  103. Shankman SA, Klein DN. The impact of comorbid anxiety disorders on the course of dysthymic disorder: a 5-year prospective longitudinal study. J Affect Disord 2002; 70:211.
  104. Coryell W, Endicott J, Keller M. Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiatry 1990; 147:1627.
  105. Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psychiatry 2001; 62 Suppl 6:5.
  106. Mueller TI, Keller MB, Leon AC, et al. Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry 1996; 53:794.
  107. Keitner GI, Ryan CE, Solomon DA. Realistic expectations and a disease management model for depressed patients with persistent symptoms. J Clin Psychiatry 2006; 67:1412.
  108. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005; 58:175.
  109. Jackson JL, DeZee K, Berbano E. Can treating depression improve disease outcomes? Ann Intern Med 2004; 140:1054.
  110. Krishnan KR. Depression as a contributing factor in cerebrovascular disease. Am Heart J 2000; 140:70.
  111. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003; 54:227.
  112. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003; 54:317.
  113. Carnethon MR, Biggs ML, Barzilay JI, et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med 2007; 167:802.
  114. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299:2751.
  115. Shen CC, Tsai SJ, Perng CL, et al. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology 2013; 81:1538.
  116. Cui X, Lyness JM, Tu X, et al. Does depression precede or follow executive dysfunction? Outcomes in older primary care patients. Am J Psychiatry 2007; 164:1221.
  117. Steffens DC, Otey E, Alexopoulos GS, et al. Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006; 63:130.
  118. Singh-Manoux A, Akbaraly TN, Marmot M, et al. Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study. J Clin Psychiatry 2010; 71:1379.
  119. Gallo JJ, Bogner HR, Morales KH, et al. Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry 2005; 13:748.
  120. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68:167.
  121. Cuijpers P, Vogelzangs N, Twisk J, et al. Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br J Psychiatry 2013; 202:22.
  122. Markkula N, Härkänen T, Perälä J, et al. Mortality in people with depressive, anxiety and alcohol use disorders in Finland. Br J Psychiatry 2012; 200:143.
  123. Gale CR, Batty GD, Osborn DP, et al. Association of mental disorders in early adulthood and later psychiatric hospital admissions and mortality in a cohort study of more than 1 million men. Arch Gen Psychiatry 2012; 69:823.
  124. Cuijpers P, Vogelzangs N, Twisk J, et al. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry 2014; 171:453.
  125. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 2015; 72:334.
  126. Laursen TM, Musliner KL, Benros ME, et al. Mortality and life expectancy in persons with severe unipolar depression. J Affect Disord 2016; 193:203.
  127. Zivin K, Ilgen MA, Pfeiffer PN, et al. Early mortality and years of potential life lost among Veterans Affairs patients with depression. Psychiatr Serv 2012; 63:823.
  128. Cuijpers P, Vogelzangs N, Twisk J, et al. Is excess mortality higher in depressed men than depressed women?, A meta-analytic comparison. J Affect Disord 2014.
  129. Chang CK, Hayes RD, Perera G, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One 2011; 6:e19590.
  130. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013; 346:f2539.
  131. Carney RM, Freedland KE, Jaffe AS, et al. Depression as a risk factor for post-MI mortality. J Am Coll Cardiol 2004; 44:472; author reply 473.
  132. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270:1819.
  133. Carney RM, Freedland KE, Steinmeyer B, et al. Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord 2008; 109:133.
  134. Mykletun A, Bjerkeset O, Overland S, et al. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry 2009; 195:118.
  135. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009; 115:5349.
  136. Pan A, Lucas M, Sun Q, et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 2011; 68:42.
  137. Hoertel N, Limosin F, Leleu H. Poor longitudinal continuity of care is associated with an increased mortality rate among patients with mental disorders: results from the French National Health Insurance Reimbursement Database. Eur Psychiatry 2014; 29:358.
  138. Hawton K, van Heeringen K. Suicide. Lancet 2009; 373:1372.
  139. Hawton K, Casañas I Comabella C, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord 2013; 147:17.
  140. Crump C, Sundquist K, Winkleby MA, Sundquist J. Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study. BMJ 2013; 346:f557.
  141. Crump C, Sundquist K, Winkleby MA, Sundquist J. Mental disorders and risk of accidental death. Br J Psychiatry 2013; 203:297.